{"podcast":{"title":"General Practice Clinical Sessions Podcast","slug":"general-practice-clinical-sessions-podcast-7705659","podcast_index_feed_id":7705659,"rss_url":"https://feeds.captivate.fm/general-practice/","website_url":"https://www.armchairmedical.tv/","image_url":"https://artwork.captivate.fm/7c6425be-c9cb-43f8-85b1-119cdf34389c/ArmchairMedical-60.png","author":"ArmchairMedical.tv/podcasts","episode_count":121,"summary":"General Practice Clinical Sessions is a GP podcast that removes the need to attend live webinars. Instead of giving up an evening with your family to watch live, or spending a weekend at a training day, you listen to the recordings here at 1.5 times the speed and while you're commuting, exercising, or doing chores around the house. It's the same education, in a fraction of the time and without the sacrifice. New episodes are delivered twice per week, so you'll always have something interesting to listen to. Subscribe to our newsletter to be notified of new sessions. https://www.armchairmedical.tv/","last_synced_at":"2026-09-20T18:22:14.442708+00:00","page_url":"https://stenobird.com/podcast/general-practice-clinical-sessions-podcast-7705659"},"episode":{"title":"Expanding Role of SGLT 2 Inhibitors and Finererone in primary care. Dr Jeremy Knott","slug":"expanding-role-of-sglt-2-inhibitors-and-finererone-in-primary-care-dr-jeremy-knott","published_at":"2026-08-10T19:30:00+00:00","page_url":"https://stenobird.com/podcast/general-practice-clinical-sessions-podcast-7705659/expanding-role-of-sglt-2-inhibitors-and-finererone-in-primary-care-dr-jeremy-knott","show_page_url":"https://stenobird.com/podcast/general-practice-clinical-sessions-podcast-7705659","url":"https://general-practice.captivate.fm/episode/expanding-role-of-sglt-2-inhibitors-and-finererone-dr-jeremy-knott","audio_url":"https://episodes.captivate.fm/episode/e340fb81-b00f-489b-9b82-94983e2f462c.mp3","summary":"Expanding Role of SGLT 2 Inhibitors and Finererone Dr Jeremy Knott In this podcast, Dr. Jeremy Knott explores the evolving landscape of diabetes management, specifically focusing on SGLT2 inhibitors and finerenone's role in addressing cardiorenal metabolic risks in type 2 diabetes. He emphasizes the need for a shift towards a comprehensive risk management strategy rather than a solely glycemic focus. The prevalence of type 2 diabetes in Australia is discussed, along with its significant associated cardiovascular risks. Dr. Knott outlines the pathophysiological mechanisms linking diabetes to cardiovascular and renal complications and presents evidence supporting the effectiveness of SGLT2 inhibitors and finerenone. He concludes with a call for early intervention and a holistic treatment approach that includes lifestyle modifications and adherence to updated clinical guidelines. Enjoyed Today's Clinical Sessions Podcast? Imagine if your favourite medical conferences were available the same way. You already know how powerful learning by podcast can be. No travel. No sitting in lecture theatres. No giving up another weekend. Just practical education from leading clinicians, ready whenever you have time to listen. That's exactly what ArmchairMedical.tv gives you. Unlock hundreds of Australia's leading GP conferences and listen while you're driving to work, exercising, walking the dog or relaxing at home. When you want the full experience, simply switch to video and follow along with synchronised presentation slides. Stay clinically up to date without putting your life on hold. Spend less time travelling to conferences. Spend more time with your friends and family and less time in auditoriums. Learn more https://www.armchairmedical.tv/podcasts -------------------------------…","meta_description":"Expanding Role of SGLT 2 Inhibitors and Finererone Dr Jeremy Knott In this podcast, Dr. Jeremy Knott explores the evolving landscape of diabetes managemen…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1127,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/general-practice-clinical-sessions-podcast-7705659/episodes/expanding-role-of-sglt-2-inhibitors-and-finererone-in-primary-care-dr-jeremy-knott/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/general-practice-clinical-sessions-podcast-7705659/expanding-role-of-sglt-2-inhibitors-and-finererone-in-primary-care-dr-jeremy-knott.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}